166 related articles for article (PubMed ID: 35967419)
1. Spindle pole body component 25 and platelet-derived growth factor mediate crosstalk between tumor-associated macrophages and prostate cancer cells.
Cui F; Xu Z; Hu J; Lv Y
Front Immunol; 2022; 13():907636. PubMed ID: 35967419
[TBL] [Abstract][Full Text] [Related]
2. Spindle pole body component 25 regulates stemness of prostate cancer cells.
Cui F; Tang H; Tan J; Hu J
Aging (Albany NY); 2018 Nov; 10(11):3273-3282. PubMed ID: 30408771
[TBL] [Abstract][Full Text] [Related]
3. SPC25 Functions as a Prognostic-Related Biomarker, and Its High Expression Correlates with Tumor Immune Infiltration and UCEC Progression.
Liao LX; Zhang M; Xu X; Zhang S; Guo YZ
Front Biosci (Landmark Ed); 2024 Feb; 29(2):69. PubMed ID: 38420826
[TBL] [Abstract][Full Text] [Related]
4. Effects of blocking platelet-derived growth factor-receptor signaling in a mouse model of experimental prostate cancer bone metastases.
Uehara H; Kim SJ; Karashima T; Shepherd DL; Fan D; Tsan R; Killion JJ; Logothetis C; Mathew P; Fidler IJ
J Natl Cancer Inst; 2003 Mar; 95(6):458-70. PubMed ID: 12644539
[TBL] [Abstract][Full Text] [Related]
5. Platelet-derived growth factor-C (PDGF-C) induces anti-apoptotic effects on macrophages through Akt and Bad phosphorylation.
Son D; Na YR; Hwang ES; Seok SH
J Biol Chem; 2014 Feb; 289(9):6225-35. PubMed ID: 24421315
[TBL] [Abstract][Full Text] [Related]
6. Stromal expression of platelet-derived growth factor beta-receptor and platelet-derived growth factor B-chain in colorectal cancer.
Lindmark G; Sundberg C; Glimelius B; Påhlman L; Rubin K; Gerdin B
Lab Invest; 1993 Dec; 69(6):682-9. PubMed ID: 8264231
[TBL] [Abstract][Full Text] [Related]
7. Prostate field cancerization: deregulated expression of macrophage inhibitory cytokine 1 (MIC-1) and platelet derived growth factor A (PDGF-A) in tumor adjacent tissue.
Jones AC; Antillon KS; Jenkins SM; Janos SN; Overton HN; Shoshan DS; Fischer EG; Trujillo KA; Bisoffi M
PLoS One; 2015; 10(3):e0119314. PubMed ID: 25767870
[TBL] [Abstract][Full Text] [Related]
8. PTEN regulates PDGF ligand switch for β-PDGFR signaling in prostate cancer.
Conley-LaComb MK; Huang W; Wang S; Shi D; Jung YS; Najy A; Fridman R; Bonfil RD; Cher ML; Chen YQ; Kim HC
Am J Pathol; 2012 Mar; 180(3):1017-1027. PubMed ID: 22209699
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-beta1-induced proliferation of the prostate cancer cell line, TSU-Pr1: the role of platelet-derived growth factor.
Sintich SM; Lamm ML; Sensibar JA; Lee C
Endocrinology; 1999 Aug; 140(8):3411-5. PubMed ID: 10433194
[TBL] [Abstract][Full Text] [Related]
10. New insights about the PDGF/PDGFR signaling pathway as a promising target to develop cancer therapeutic strategies.
Pandey P; Khan F; Upadhyay TK; Seungjoon M; Park MN; Kim B
Biomed Pharmacother; 2023 May; 161():114491. PubMed ID: 37002577
[TBL] [Abstract][Full Text] [Related]
11. Crosstalk between Cancer Cells and Fibroblasts for the Production of Monocyte Chemoattractant Protein-1 in the Murine 4T1 Breast Cancer.
Imamura M; Li T; Li C; Fujisawa M; Mukaida N; Matsukawa A; Yoshimura T
Curr Issues Mol Biol; 2021 Oct; 43(3):1726-1740. PubMed ID: 34698088
[TBL] [Abstract][Full Text] [Related]
12. Signal transduction proteins that associate with the platelet-derived growth factor (PDGF) receptor mediate the PDGF-induced release of glucose-6-phosphate dehydrogenase from permeabilized cells.
Tian WN; Pignatare JN; Stanton RC
J Biol Chem; 1994 May; 269(20):14798-805. PubMed ID: 8182086
[TBL] [Abstract][Full Text] [Related]
13. PDGF/PDGFR signaling and targeting in cancer growth and progression: Focus on tumor microenvironment and cancer-associated fibroblasts.
Gialeli C; Nikitovic D; Kletsas D; Theocharis AD; Tzanakakis GN; Karamanos NK
Curr Pharm Des; 2014; 20(17):2843-8. PubMed ID: 23944365
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of platelet-derived growth factor-mediated signal transduction and tumor growth by N-[4-(trifluoromethyl)-phenyl]5-methylisoxazole-4-carboxamide.
Shawver LK; Schwartz DP; Mann E; Chen H; Tsai J; Chu L; Taylorson L; Longhi M; Meredith S; Germain L; Jacobs JS; Tang C; Ullrich A; Berens ME; Hersh E; McMahon G; Hirth KP; Powell TJ
Clin Cancer Res; 1997 Jul; 3(7):1167-77. PubMed ID: 9815796
[TBL] [Abstract][Full Text] [Related]
15. Spindle pole body component 25 in the androgen-induced regression of castration-resistant prostate cancer.
Cui F; Ning S; Xu Z; Hu J
Transl Androl Urol; 2022 Apr; 11(4):519-527. PubMed ID: 35558271
[TBL] [Abstract][Full Text] [Related]
16. Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors.
Lokker NA; Sullivan CM; Hollenbach SJ; Israel MA; Giese NA
Cancer Res; 2002 Jul; 62(13):3729-35. PubMed ID: 12097282
[TBL] [Abstract][Full Text] [Related]
17. PDGF-AA mediates mesenchymal stromal cell chemotaxis to the head and neck squamous cell carcinoma tumor microenvironment.
Watts TL; Cui R; Szaniszlo P; Resto VA; Powell DW; Pinchuk IV
J Transl Med; 2016 Dec; 14(1):337. PubMed ID: 27931212
[TBL] [Abstract][Full Text] [Related]
18. Differences in substrate specificities of alpha and beta platelet-derived growth factor (PDGF) receptors. Correlation with their ability to mediate PDGF transforming functions.
Heidaran MA; Beeler JF; Yu JC; Ishibashi T; LaRochelle WJ; Pierce JH; Aaronson SA
J Biol Chem; 1993 May; 268(13):9287-95. PubMed ID: 8387491
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of spindle pole body component 25 homolog inhibits cell proliferation and cycle progression in prostate cancer.
Cui F; Hu J; Fan Y; Tan J; Tang H
Oncol Lett; 2018 Apr; 15(4):5712-5720. PubMed ID: 29552205
[TBL] [Abstract][Full Text] [Related]
20. Platelet-derived growth factor (PDGF)-PDGF receptor interaction activates bone marrow-derived mesenchymal stromal cells derived from chronic lymphocytic leukemia: implications for an angiogenic switch.
Ding W; Knox TR; Tschumper RC; Wu W; Schwager SM; Boysen JC; Jelinek DF; Kay NE
Blood; 2010 Oct; 116(16):2984-93. PubMed ID: 20606160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
